Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Audrey, Margogne"'
Autor:
Suzy M. Scholl, Philippe Beuzeboc, Sébastien Armanet, Corine Plancher, Benard Asselain, Alhassane Diallo, Virginie Fourchotte, AnaTereza Nadan, Audrey Margogne, Ivan Bieche, Quentin Leroy, Virginie Bernard, Karine Peignaux, Laurence Gladieff, Maud Aumont, Dominique Berton-Rigaud, Laurence Gonzague, Mathieu Minsat, Claire Brunaud, Béatrice Weber, Hervé Curé, Sophie Maillard, Emmanuel Sevin, Florence Joly, Christine Kerr, Michel Fabbro, Marius Pop, Thierry Petit, Peter Petrow, Laurence Thomas, Anne Floquet, Maud Kamal, Anne de la Rochefordiere
Purpose: EGFR is frequently overexpressed in cervical cancer, suggesting EGFR blockade as a promising treatment approach. Cetuximab, an anti EGFR antibody, used conjointly with radiochemotherapy, was feasible in first-line treatment of cervix carcino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b169a22951a7aa96706287286e6b2f99
https://doi.org/10.1158/1078-0432.c.6523898
https://doi.org/10.1158/1078-0432.c.6523898
Autor:
Suzy M. Scholl, Philippe Beuzeboc, Sébastien Armanet, Corine Plancher, Benard Asselain, Alhassane Diallo, Virginie Fourchotte, AnaTereza Nadan, Audrey Margogne, Ivan Bieche, Quentin Leroy, Virginie Bernard, Karine Peignaux, Laurence Gladieff, Maud Aumont, Dominique Berton-Rigaud, Laurence Gonzague, Mathieu Minsat, Claire Brunaud, Béatrice Weber, Hervé Curé, Sophie Maillard, Emmanuel Sevin, Florence Joly, Christine Kerr, Michel Fabbro, Marius Pop, Thierry Petit, Peter Petrow, Laurence Thomas, Anne Floquet, Maud Kamal, Anne de la Rochefordiere
supplementary table 4. Multivariate analysis for Complete Clinical Response and Figo stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e952070532ae1ef92641a6f0bea7717
https://doi.org/10.1158/1078-0432.22458284
https://doi.org/10.1158/1078-0432.22458284
Autor:
Suzy M. Scholl, Philippe Beuzeboc, Sébastien Armanet, Corine Plancher, Benard Asselain, Alhassane Diallo, Virginie Fourchotte, AnaTereza Nadan, Audrey Margogne, Ivan Bieche, Quentin Leroy, Virginie Bernard, Karine Peignaux, Laurence Gladieff, Maud Aumont, Dominique Berton-Rigaud, Laurence Gonzague, Mathieu Minsat, Claire Brunaud, Béatrice Weber, Hervé Curé, Sophie Maillard, Emmanuel Sevin, Florence Joly, Christine Kerr, Michel Fabbro, Marius Pop, Thierry Petit, Peter Petrow, Laurence Thomas, Anne Floquet, Maud Kamal, Anne de la Rochefordiere
supplementary table 2. Protocol�defined treatment�related Adverse Events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a88e1799676f4710a1d233279751361
https://doi.org/10.1158/1078-0432.22458290
https://doi.org/10.1158/1078-0432.22458290
Autor:
Suzy M. Scholl, Philippe Beuzeboc, Sébastien Armanet, Corine Plancher, Benard Asselain, Alhassane Diallo, Virginie Fourchotte, AnaTereza Nadan, Audrey Margogne, Ivan Bieche, Quentin Leroy, Virginie Bernard, Karine Peignaux, Laurence Gladieff, Maud Aumont, Dominique Berton-Rigaud, Laurence Gonzague, Mathieu Minsat, Claire Brunaud, Béatrice Weber, Hervé Curé, Sophie Maillard, Emmanuel Sevin, Florence Joly, Christine Kerr, Michel Fabbro, Marius Pop, Thierry Petit, Peter Petrow, Laurence Thomas, Anne Floquet, Maud Kamal, Anne de la Rochefordiere
supplementary table 3. Response evaluation at 2 time points
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::210d5039bb658b60425ae97530e92071
https://doi.org/10.1158/1078-0432.22458287
https://doi.org/10.1158/1078-0432.22458287
Autor:
Suzy M. Scholl, Philippe Beuzeboc, Sébastien Armanet, Corine Plancher, Benard Asselain, Alhassane Diallo, Virginie Fourchotte, AnaTereza Nadan, Audrey Margogne, Ivan Bieche, Quentin Leroy, Virginie Bernard, Karine Peignaux, Laurence Gladieff, Maud Aumont, Dominique Berton-Rigaud, Laurence Gonzague, Mathieu Minsat, Claire Brunaud, Béatrice Weber, Hervé Curé, Sophie Maillard, Emmanuel Sevin, Florence Joly, Christine Kerr, Michel Fabbro, Marius Pop, Thierry Petit, Peter Petrow, Laurence Thomas, Anne Floquet, Maud Kamal, Anne de la Rochefordiere
supplementary table 1. Radiotherapy and Chemotherapy Treatment dose and Surgery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1da0aaf2d46fdbf558edaaf8c4b55a4
https://doi.org/10.1158/1078-0432.22458293
https://doi.org/10.1158/1078-0432.22458293
Autor:
Anne de la Rochefordière, Ivan Bièche, Virginie Fourchotte, Florence Joly, Emmanuel Sevin, Béatrice Weber, Mathieu Minsat, Benard Asselain, Anne Floquet, Maud Kamal, Suzy Scholl, Maud Aumont, Quentin Leroy, Laurence Thomas, Marius Pop, Alhassane Diallo, Sophie Maillard, Hervé Curé, Michel Fabbro, Peter Petrow, Philippe Beuzeboc, Thierry Petit, K. Peignaux, Laurence Gladieff, Corine Plancher, Laurence Gonzague, Virginie Bernard, Claire Brunaud, Christine Kerr, Dominique Berton-Rigaud, AnaTereza Nadan, Sebastien Armanet, Audrey Margogne
Publikováno v:
Clinical Cancer Research. 21:2530-2537
Purpose: EGFR is frequently overexpressed in cervical cancer, suggesting EGFR blockade as a promising treatment approach. Cetuximab, an anti EGFR antibody, used conjointly with radiochemotherapy, was feasible in first-line treatment of cervix carcino
Autor:
Pascale, Mariani, Marick, Lae, Armelle, Degeorges, Wulfran, Cacheux, Emmanuelle, Lappartient, Audrey, Margogne, Jean-Yves, Pierga, Véronique, Girre, Laurent, Mignot, Marie Christine, Falcou, Rémy-Jacques, Salmon, Olivier, Delattre, Patricia, De Cremoux
Publikováno v:
Anticancer research. 30(10)
KRAS somatic mutations are the main predictive factor for non response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer (mCRC) patients. We compared KRAS mutational status in the primary tumour and the corresponding metastases (